Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy-Reference-Cited by-同舟云学术

Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy

Published:2005 Issue:8 Volume:104 Page:1580-1589
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Peppercorn Jeffrey,Herndon James,Kornblith Alice B.,Peters William,Ahles Tim,Vredenburgh James,Schwartz Gary,Shpall Elizabeth,Hurd David D.,Holland Jimmie,Winer Eric,

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference32 articles.

1. Long-term prognosis of breast cancer patients with 10 or more positive lymph nodes treated with CMF

2. Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy

3. The natural history of breast cancer with more than 10 positive nodes

4. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.

5. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Characterization of Paclitaxel-Loaded Silver Nanoparticles: Evaluation of Cytotoxic Effects and Antimicrobial Activity;Bioinorganic Chemistry and Applications;2024-02-13

2. Novel archetype in cancer therapeutics: exploring prospective of phytonanocarriers;3 Biotech;2022-10-15

3. Nanotechnology: An Emerging Field in Protein Aggregation and Cancer Therapeutics;Bio-Nano Interface;2021-11-28

4. Silver Nanoparticles Potentiates Cytotoxicity and Apoptotic Potential of Camptothecin in Human Cervical Cancer Cells;Oxidative Medicine and Cellular Longevity;2018-12-12

5. High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer;Cochrane Database of Systematic Reviews;2016-05-20